These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 10570102

  • 1. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.
    Hueso M, Bover J, Serón D, Gil-Vernet S, Rufí G, Alsina J, Grinyó JM.
    Nephrol Dial Transplant; 1999 Dec; 14(12):2941-3. PubMed ID: 10570102
    [No Abstract] [Full Text] [Related]

  • 2. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
    Kuyucu N, Kara C, Bakirtaç A, Teziç T.
    Pediatr Infect Dis J; 2001 Apr; 20(4):455-7. PubMed ID: 11332679
    [Abstract] [Full Text] [Related]

  • 3. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
    di Martino L, Mantovani MP, Gradoni L, Gramiccia M, Guandalini S.
    Trans R Soc Trop Med Hyg; 1990 Apr; 84(4):534-5. PubMed ID: 2091347
    [No Abstract] [Full Text] [Related]

  • 4. Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV.
    Laguna F, López-Vélez R, Soriano V, Montilla P, Alvar J, González-Lahoz JM.
    J Infect; 1994 May; 28(3):255-9. PubMed ID: 8089514
    [Abstract] [Full Text] [Related]

  • 5. Treatment of kala azar.
    Ozsoylu S.
    Lancet; 1996 Jun 15; 347(9016):1701. PubMed ID: 8642997
    [No Abstract] [Full Text] [Related]

  • 6. Chemotherapy of leishmaniasis in India.
    Thakur CP.
    Indian J Pediatr; 1987 Jun 15; 54(1):7-10. PubMed ID: 3030933
    [No Abstract] [Full Text] [Related]

  • 7. Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
    Verdejo J, Alvar J, Polo RM, González-Lahoz JM.
    Am J Med; 1988 Jul 15; 85(1):128. PubMed ID: 3389377
    [No Abstract] [Full Text] [Related]

  • 8. Fulminant hepatitis in an Italian infant with visceral leishmaniasis.
    di Martino L, Vajro P, Nocerino A, Scotti S, Napolitano G, Vegnente A.
    Trans R Soc Trop Med Hyg; 1992 Jul 15; 86(1):34. PubMed ID: 1566298
    [No Abstract] [Full Text] [Related]

  • 9. Combined antimonial allopurinol therapy in mucosal leishmaniasis.
    Sampaio RN, Marchán EM, Vexenat A, Tristão RJ, Marsden PD.
    Mem Inst Oswaldo Cruz; 1990 Jul 15; 85(3):373-4. PubMed ID: 2134714
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of aminosidine administered alone or in combination with meglumine antimoniate for the treatment of experimental visceral leishmaniasis caused by Leishmania infantum.
    Gangneux JP, Sulahian A, Garin YJ, Derouin F.
    J Antimicrob Chemother; 1997 Aug 15; 40(2):287-9. PubMed ID: 9301998
    [Abstract] [Full Text] [Related]

  • 11. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
    Amusategui I, Sainz A, Tesouro MA.
    Ann N Y Acad Sci; 1998 Jun 29; 849():447-9. PubMed ID: 9668510
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of combined therapy with liposome-encapsulated meglumine antimoniate and allopurinol in treatment of canine visceral leishmaniasis.
    da Silva SM, Amorim IF, Ribeiro RR, Azevedo EG, Demicheli C, Melo MN, Tafuri WL, Gontijo NF, Michalick MS, Frézard F.
    Antimicrob Agents Chemother; 2012 Jun 29; 56(6):2858-67. PubMed ID: 22411610
    [Abstract] [Full Text] [Related]

  • 13. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
    de Lalla F, Pellizzer G, Gradoni L, Vespignani M, Franzetti M, Stecca C.
    Clin Infect Dis; 1993 May 29; 16(5):730-1. PubMed ID: 8507769
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
    Laguna F, López-Vélez R, Pulido F, Salas A, Torre-Cisneros J, Torres E, Medrano FJ, Sanz J, Picó G, Gómez-Rodrigo J, Pasquau J, Alvar J.
    AIDS; 1999 Jun 18; 13(9):1063-9. PubMed ID: 10397536
    [Abstract] [Full Text] [Related]

  • 15. Visceral leishmaniasis during pregnancy treated with meglumine antimoniate.
    Utili R, Rambaldi A, Tripodi MF, Andreana A.
    Infection; 1995 Jun 18; 23(3):182-3. PubMed ID: 7499009
    [Abstract] [Full Text] [Related]

  • 16. Recent advances in the treatment of visceral leishmaniasis.
    Davidson RN, Croft SL.
    Trans R Soc Trop Med Hyg; 1993 Jun 18; 87(2):130-1, 141. PubMed ID: 8393221
    [No Abstract] [Full Text] [Related]

  • 17. Visceral leishmaniasis in a patient with human immunodeficiency virus.
    Rizzi M, Arici C, Bonaccorso C, Gavazzeni G.
    Trans R Soc Trop Med Hyg; 1988 Jun 18; 82(4):565. PubMed ID: 3256108
    [No Abstract] [Full Text] [Related]

  • 18. Electrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol.
    Antezana G, Zeballos R, Mendoza C, Lyevre P, Valda L, Cardenas F, Noriega I, Ugarte H, Dedet JP.
    Trans R Soc Trop Med Hyg; 1992 Jun 18; 86(1):31-3. PubMed ID: 1566297
    [Abstract] [Full Text] [Related]

  • 19. Allopurinol in the treatment of American cutaneous leishmaniasis.
    Martinez S, Marr JJ.
    N Engl J Med; 1992 Mar 12; 326(11):741-4. PubMed ID: 1738379
    [Abstract] [Full Text] [Related]

  • 20. Severe leucopenia during treatment of visceral leishmaniasis.
    Hiçsönmez G, Jama H, Ozsoylu S.
    Trans R Soc Trop Med Hyg; 1988 Mar 12; 82(3):417. PubMed ID: 3232176
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.